Nektar Therapeutics on Monday sued Eli Lilly, accusing the drugmaker of undermining the prospects for Rezpeg, which Nektar was developing as a treatment for various autoimmune diseases.
The complaint filed in San Francisco federal court accuses Lilly of breach of contract, negligent misrepresentation, unfair competition and other wrongdoing. It seeks compensatory and punitive damages, among other remedies.
https://finance.yahoo.com/news/nektar-therapeutics-sues-eli-lilly-142336423.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.